Sign Out
Known hypersensitivity to deferasirox or any component of the formulation.
Crcl < 40 mL/minute or serum creatinine > 2 times the age-appropriate ULN;
High-risk myelodysplastic syndromes (MDS) patients and patients with other hematological and non-hematological malignancies who are not expected to benefit from chelation therapy due to the rapid progression of their disease.
